Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
Schrock, A.B., Ouyang, C., Sandhu, J., Sokol, E., Jin, D., Ross, J.S., Miller, V.A., Lim, D., Amanam, I., Chao, J., Catenacci, D., Cho, M., Braiteh, F., Klempner, S.J., Ali, S.M., Fakih, M.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Therapeutic antibodies: A new era in the treatment of respiratory diseases?
Sécher, T., Guilleminault, L., Reckamp, K., Amanam, I., Plantier, L., Heuzé-Vourc'h, N.
Published in Pharmacology & therapeutics (Oxford) (01.09.2018)
Published in Pharmacology & therapeutics (Oxford) (01.09.2018)
Get full text
Journal Article
Lower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC)
Amanam, I, Chao, J, Lim, D, Rahmanuddin, S, Schrock, A B, Ali, S M, Lau, C, Chevalier, D, Harris, E, Saluja, J, Wang, C, Fakih, M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The potential role of immune regulation in the presentation of early vs. advanced ovarian cancer
Harris, K, Kiet, T, Amanam, I, Chen, L, Brooks, R, Ueda, S, Kapp, D, Chan, J
Published in Gynecologic oncology (01.10.2012)
Published in Gynecologic oncology (01.10.2012)
Get full text
Journal Article
Improved outcomes of younger compared to older ovarian cancer patients — What is the role of immune regulation?
Simons, E, Kiet, T, Amanam, I, Chen, L, Brooks, R, Ueda, S, Kapp, D, Chan, J
Published in Gynecologic oncology (01.10.2012)
Published in Gynecologic oncology (01.10.2012)
Get full text
Journal Article
Differences in tumor immune regulation between African–American and Caucasian ovarian cancer patients
Ruskin, R, Kiet, T, Amanam, I, Chen, L, Brooks, R, Ueda, S, Kapp, D, Chan, J
Published in Gynecologic oncology (01.10.2012)
Published in Gynecologic oncology (01.10.2012)
Get full text
Journal Article
Immune signatures predictive of optimal cytoreduction in ovarian cancer
Simons, E, Kiet, T, Amanam, I, Ho, M, Fuh, J, Fuh, K, Kapp, D, Odunsi, K, Chan, J
Published in Gynecologic oncology (01.03.2012)
Published in Gynecologic oncology (01.03.2012)
Get full text
Journal Article
Immune biomarkers predictive of survival in epithelial ovarian cancer
Simons, E, Kiet, T, Amanam, I, Ho, M, Fuh, J, Fuh, K, Kapp, D, Odunsi, K, Chan, J
Published in Gynecologic oncology (01.03.2012)
Published in Gynecologic oncology (01.03.2012)
Get full text
Journal Article
Immune biomarkers associated with response to intra-peritoneal chemotherapy in ovarian cancer
Simons, E, Kiet, T, Amanam, I, Ho, M, Fuh, J, Fuh, K, Kapp, D, Odunsi, K, Chan, J
Published in Gynecologic oncology (01.03.2012)
Published in Gynecologic oncology (01.03.2012)
Get full text
Journal Article
Trends and progress of oncology drug development — An analysis of the FDA oncologic drug advisory committee reviews
Amanam, I, Kiet, T, Young-Lin, N, Chen, L, Brooks, R, Ueda, S, Monk, B, Kapp, D, Hoth, D, Chan, J
Published in Gynecologic oncology (01.10.2012)
Published in Gynecologic oncology (01.10.2012)
Get full text
Journal Article
Applications for oncologic drugs — Lessons from the oncologic drug advisory committee
Amanam, I, Kiet, T, Young-Lin, N, Chen, L, Brooks, R, Ueda, S, Monk, B, Kapp, D, Hoth, D, Chan, J
Published in Gynecologic oncology (01.10.2012)
Published in Gynecologic oncology (01.10.2012)
Get full text
Journal Article
Predictive model for cancer drug approval – An analysis of FDA drug submissions over the last decade
Amanam, I, Kiet, T, Young-Lin, N, Chen, L, Brooks, R, Ueda, S, Monk, B, Kapp, D, Hoth, D, Chan, J
Published in Gynecologic oncology (01.10.2012)
Published in Gynecologic oncology (01.10.2012)
Get full text
Journal Article
94 Comparative benefit of olaparib in recurrent BRCAm ovarian, breast, pancreatic and prostate cancer
Peters, P, Manrriquez, E, Amanam, I, Chan, J
Published in International journal of gynecological cancer (01.11.2020)
Published in International journal of gynecological cancer (01.11.2020)
Get full text
Journal Article
MS 25.02 KRAS-Targeted Therapy or Angiogenesis: Still a Viable Target?
Mambetsariev, I., Amanam, I., Nam, A., Salgia, R.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article
KRAS in non-small cell lung cancer
Amanam, I., Gupta, R., Mambetsariev, I., Koczywas, M., Cristea, M., Massarelli, E., Reckamp, K.L., Salgia, R.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
P2.01-06 HSP72 Expression Associates with Survival in EGFR Mutated NSCLC
Amanam, I., Frankel, P., Mach, S., Dickinson, E., Zheng, L., Shen, B., Reckamp, K.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article